(Q48313320)

English

Memantine-induced brain activation as a model for the rapid screening of potential novel antipsychotic compounds: exemplified by activity of an mGlu2/3 receptor agonist.

scientific article published on 31 October 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/21057775

Memantine-induced brain activation as a model for the rapid screening of potential novel antipsychotic compounds: exemplified by activity of an mGlu2/3 receptor agonist. (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/21057775

Stefanie Dedeurwaerdere

1

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/21057775

Xavier Langlois

5

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/21057775

Cindy Wintmolders

2

object named as

Cindy Wintmolders

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/21057775

author name string

Roel Straetemans

3

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/21057775

Darrel Pemberton

4

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/21057775

publication date

31 October 2010

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/21057775

number of pages

10

1 reference

based on heuristic

inferred from page(s)

Psychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/21057775

214

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/21057775

2

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/21057775

505-514

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/21057775

https://scigraph.springernature.com/pub.10.1007/s00213-010-2052-z

0 references

Memantine lowers amyloid-beta peptide levels in neuronal cultures and in APP/PS1 transgenic mice.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2052-Z

21 January 2018

Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2052-Z

21 January 2018

Anesthesia can cause sustained hyperglycemia in C57/BL6J mice

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2052-Z

21 January 2018

Differential effects of acute administration of clozapine or haloperidol on local cerebral glucose utilization in the rat.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2052-Z

21 January 2018

Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2052-Z

21 January 2018

Novel analysis for improved validity in semi-quantitative 2-deoxyglucose autoradiographic imaging

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2052-Z

21 January 2018

Neurochemical, electrophysiological and pharmacological profiles of the selective inhibitor of the glycine transporter-1 SSR504734, a potential new type of antipsychotic

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2052-Z

21 January 2018

Differential effects of clozapine and haloperidol on ketamine-induced brain metabolic activation.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2052-Z

21 January 2018

Metabolic mapping of the rat brain after subanesthetic doses of ketamine: potential relevance to schizophrenia.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2052-Z

21 January 2018

Effects of diazepam and ketamine administered individually or in combination on regional rates of glucose utilization in rat brain

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2052-Z

21 January 2018

Potency, voltage-dependency, agonist concentration-dependency, blocking kinetics and partial untrapping of the uncompetitive N-methyl-D-aspartate (NMDA) channel blocker memantine at human NMDA (GluN1/GluN2A) receptors

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2052-Z

21 January 2018

Diverse and often opposite behavioural effects of NMDA receptor antagonists in rats: implications for "NMDA antagonist modelling" of schizophrenia.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2052-Z

21 January 2018

The acute effects of NMDA antagonism: from the rodent to the human brain

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2052-Z

21 January 2018

Effects of noncompetitive NMDA receptor blockade on anterior cingulate cerebral blood flow in volunteers with schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2052-Z

21 January 2018

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2052-Z

21 January 2018

Effects of MK-801 upon local cerebral glucose utilisation in conscious rats and in rats anaesthetised with halothane.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2052-Z

21 January 2018

A randomized, placebo-controlled study of memantine as adjunctive treatment in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2052-Z

21 January 2018

Progress towards validating the NMDA receptor hypofunction hypothesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2052-Z

21 January 2018

NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2052-Z

21 January 2018

Ketamine produces lasting disruptions in encoding of sensory stimuli

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2052-Z

21 January 2018

Mechanisms of action of antipsychotic drugs of different classes, refractoriness to therapeutic effects of classical neuroleptics, and individual variation in sensitivity to their actions: Part I.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2052-Z

21 January 2018

Effects of ketamine, MK-801, and amphetamine on regional brain 2-deoxyglucose uptake in freely moving mice.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2052-Z

21 January 2018

NMDA receptor hypofunction model of schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2052-Z

21 January 2018

Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system--too little activation is bad, too much is even worse

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2052-Z

21 January 2018

Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2052-Z

21 January 2018

Pharmacotoxic psychosis after memantine in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2052-Z

21 January 2018

In vivo pharmacological characterization of the structurally novel, potent, selective mGlu2/3 receptor agonist LY404039 in animal models of psychiatric disorders

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2052-Z

21 January 2018

The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2052-Z

21 January 2018

Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET)

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2052-Z

21 January 2018

Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDG).

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2052-Z

21 January 2018

In vivo evidence for ligand-specific receptor activation in the central CRF system, as measured by local cerebral glucose utilization.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2052-Z

21 January 2018

Differential effects of ketamine enantiomers on NMDA receptor currents in cultured neurons

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2052-Z

21 January 2018

Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21057775

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ketamine activates psychosis and alters limbic blood flow in schizophrenia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21057775

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Topographic patterns of brain activity in response to swim stress: assessment by 2-deoxyglucose uptake and expression of Fos-like immunoreactivity

1 reference

https://pubmed.ncbi.nlm.nih.gov/21057775

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Blockade of phencyclidine-induced hyperlocomotion by olanzapine, clozapine and serotonin receptor subtype selective antagonists in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/21057775

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential effects of antipsychotic and glutamatergic agents on the phMRI response to phencyclidine

1 reference

https://pubmed.ncbi.nlm.nih.gov/21057775

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the effects of clozapine, risperidone, and olanzapine on ketamine-induced alterations in regional brain metabolism.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21057775

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Optimizing experimental protocols for quantitative behavioral imaging with 18F-FDG in rodents.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21057775

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development of subtle psychotic symptoms with memantine: a case report.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21057775

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00213-010-2052-Z

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/21057775

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/21057775

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48313320&oldid=1786046090"